dan 2163 has been researched along with bupropion in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Laux, G; Livak, V; Neumann, M; Paul, HW | 1 |
Brennan, CH; Brock, AJ; Busch-Nentwich, EM; García-González, J; Joliffe, D; Kaprio, J; Kuan, V; Martineau, AR; Palviainen, T; Parker, MO; Riley, RJ; Stemple, DL; Sudwarts, A; Teh, MT; Walton, RT | 1 |
4 other study(ies) available for dan 2163 and bupropion
Article | Year |
---|---|
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Acute psychosis after administration of bupropion hydrochloride (Zyban).
Topics: Adult; Amisulpride; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Bupropion; Hallucinations; Humans; Male; Psychoses, Substance-Induced; Smoking Cessation; Sulpiride | 2002 |
Identification of
Topics: Amisulpride; Animals; Bupropion; Choice Behavior; Conditioning, Classical; Female; Genetic Loci; Humans; Intracellular Signaling Peptides and Proteins; Male; Membrane Proteins; Mutation; Nicotine; Polymorphism, Single Nucleotide; Receptor, Serotonin, 5-HT1A; Tobacco Smoking; Zebrafish; Zebrafish Proteins | 2020 |